Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fedratinib hydrochloride hydrate (SAR 302503 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 13,000 | |||
25 mg | 在庫あり | ¥ 18,000 | |||
50 mg | 在庫あり | ¥ 23,500 | |||
100 mg | 在庫あり | ¥ 28,000 | |||
200 mg | お問い合わせ | ¥ 45,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 14,000 |
説明 | Fedratinib hydrochloride hydrate (SAR 302503 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor. |
ターゲット&IC50 | JAK2:3 nM, FLT3:15 nM, RET:48 nM, JAK2 (V617F):3 nM |
別名 | TG-101348 hydrochloride hydrate, SAR 302503 hydrochloride hydrate |
分子量 | 615.61 |
分子式 | C27H40Cl2N6O4S |
CAS No. | 1374744-69-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (194.92 mM), Sonication is recommended.
H2O: 97 mg/mL (157.56 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fedratinib hydrochloride hydrate 1374744-69-0 Angiogenesis Apoptosis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK STAT5 JAK2V617F myeloproliferative TG-101348 hydrochloride Janus kinase phosphorylation anti-proliferation TG-101348 hydrochloride hydrate FLT3 inhibit TG-101348 hydrochloride Hydrate RET SAR 302503 hydrochloride hydrate orally Fedratinib hydrochloride Hydrate SAR 302503 hydrochloride anti-cancer SAR 302503 hydrochloride Hydrate JAK2 Inhibitor Fedratinib hydrochloride inhibitor